Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript BNGO earnings call for the period ending December 31, 2024.…
Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect SAN DIEGO, and GREENWOOD, S.C., March 24, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) and Greenwood Genetic…
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript BNGO earnings call for the period ending September 30, 2024.…
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of…
Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript BNGO earnings call for the period ending June 30, 2024.…
Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript BNGO earnings call for the period ending March 31, 2024.…
Bionano Genomics stock price target cut to $3 amid restructuring By Investing.com Bionano Genomics stock price target cut to $3 amid restructuring…
Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript BNGO earnings call for the period ending December 31, 2023.…
Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024 SAN DIEGO, March 05, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for…
Bionano to Present at TD Cowen’s 44th Annual Health Care Conference SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin,…